Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Characterization of zebrafish models of very-long-chain polyunsaturated fatty acid depletion and Stargardt 3 disease
Author Affiliations & Notes
  • Uzoamaka Nwagbo
    Pharmacology & Toxicology, University of Utah Health, Salt Lake City, Utah, United States
    Ophthalmology & Visual Sciences, University of Utah Health, Salt Lake City, Utah, United States
  • Paul S Bernstein
    Ophthalmology & Visual Sciences, University of Utah Health, Salt Lake City, Utah, United States
    Pharmacology & Toxicology, University of Utah Health, Salt Lake City, Utah, United States
  • Footnotes
    Commercial Relationships   Uzoamaka Nwagbo None; Paul Bernstein None
  • Footnotes
    Support  NIH EY34497 and EY14800; Foundation Fighting Blindness; Research to Prevent Blindness
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 4648. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Uzoamaka Nwagbo, Paul S Bernstein; Characterization of zebrafish models of very-long-chain polyunsaturated fatty acid depletion and Stargardt 3 disease. Invest. Ophthalmol. Vis. Sci. 2024;65(7):4648.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Very-long-chain polyunsaturated fatty acids (VLC-PUFAs) are a class of non-dietary lipids found in the retina and a few other tissues in vertebrates. VLC-PUFAs comprise <2% of the fatty acids in the retina and are depleted in retinal disorders such as diabetic retinopathy, age-related macular degeneration, and Stargardt 3 disease (STGD3). Their exact roles in the retina and contribution to retinal disease pathology are largely unknown. Certain mutations in exon 6 of ELOVL4 that cause STGD3 lead to premature termination and truncation of the ELOVL4 protein, which causes a loss of catalytic activity and cytoplasmic aggregation. As mouse models of global ELOVL4-ablation are not useful due to neonatal skin drying, we turned to zebrafish to understand the effects of VLC-PUFA depletion and protein mislocalization on vision. We hypothesized that mutations in zebrafish Elovl4 would lead to the loss of ocular VLC-PUFAs, lipid abnormalities, and visual dysfunction.

Methods : Using CRISPR-Cas9, we induced deletions without neonatal mortality in exon 2 of Elovl4b (knockout of VLC-PUFA synthesis), exon 3 of Elovl4a (knockout of very-long-chain saturated fatty acid synthesis), and a homology-driven repair insertion of the two-1-bp-deletion mutation in exon 7 of Elovl4b (STGD3 knock-in). This complex mutation was first identified in a Utah family with STGD3. We confirmed germline mutagenesis by sequencing the gene loci in F2 progeny. We performed visual motor response (VMR) tests using a ViewPoint ZebraBox system.

Results : Homozygous Elovl4b knockout (KO) fish had depleted ocular levels of C30-C36 VLC-PUFAs and significant depletions in glycerophospholipids containing C30 and C32 VLC-PUFAs, but an upregulation of C26 acylcarnitine. They had no difference in gross retinal morphology but had abnormal lipid deposits in their retinal pigment epithelium. Homozygous Elovl4a knockout fish were infertile and smaller than heterozygous mutants and wild-type controls. Homozygous STGD3 knock-in fish are viable and fertile but are exclusively female. All Elovl4 mutants displayed varying VMR phenotypes between 5-6 days post-fertilization.

Conclusions : We generated viable zebrafish models of STGD3 and Elovl4-ablation. The models can be used to understand STGD3 pathology and differentiate the role of VLC-PUFA depletion from STGD3 protein aggregation in visual function and photoreceptor viability.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×